169 related articles for article (PubMed ID: 29311822)
1. The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier.
Liu J; Liu L; Chao S; Liu Y; Liu X; Zheng J; Chen J; Gong W; Teng H; Li Z; Wang P; Xue Y
Front Cell Neurosci; 2017; 11():358. PubMed ID: 29311822
[TBL] [Abstract][Full Text] [Related]
2. MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5.
Chen L; Xue Y; Zheng J; Liu X; Liu J; Chen J; Li Z; Xi Z; Teng H; Wang P; Liu L; Liu Y
Front Mol Neurosci; 2018; 11():35. PubMed ID: 29467620
[TBL] [Abstract][Full Text] [Related]
3. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism.
Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
[TBL] [Abstract][Full Text] [Related]
4. Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Liu J; Yao YL; Ma J
J Mol Neurosci; 2015 Sep; 57(1):11-20. PubMed ID: 26087743
[TBL] [Abstract][Full Text] [Related]
5. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Liu LB; Wang P
J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
[TBL] [Abstract][Full Text] [Related]
6. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.
Xie H; Xue YX; Liu LB; Liu YH
Brain Res; 2010 Mar; 1319():13-20. PubMed ID: 20083091
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms for endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Liu LB; Xie H
J Mol Neurosci; 2012 Jun; 47(2):408-17. PubMed ID: 21969114
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
[TBL] [Abstract][Full Text] [Related]
9. Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB.
Xie H; Xue YX; Liu LB; Liu YH; Wang P
J Mol Neurosci; 2012 Mar; 46(3):666-76. PubMed ID: 21647708
[TBL] [Abstract][Full Text] [Related]
10. Additive effect of low-frequency ultrasound and endothelial monocyte-activating polypeptide II on blood-tumor barrier in rats with brain glioma.
Zhang Z; Xue Y; Liu Y; Shang X
Neurosci Lett; 2010 Aug; 481(1):21-5. PubMed ID: 20600613
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via Krüppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin.
Zhao YY; Zhao LN; Wang P; Miao YS; Liu YH; Wang ZH; Ma J; Li Z; Li ZQ; Xue YX
J Neurosci Res; 2015 Dec; 93(12):1891-902. PubMed ID: 26356851
[TBL] [Abstract][Full Text] [Related]
12. MiR-18a increased the permeability of BTB via RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5.
Miao YS; Zhao YY; Zhao LN; Wang P; Liu YH; Ma J; Xue YX
Cell Signal; 2015 Jan; 27(1):156-67. PubMed ID: 25452107
[TBL] [Abstract][Full Text] [Related]
13. The Role of HOTAIR/miR-148b-3p/USF1 on Regulating the Permeability of BTB.
Sa L; Li Y; Zhao L; Liu Y; Wang P; Liu L; Li Z; Ma J; Cai H; Xue Y
Front Mol Neurosci; 2017; 10():194. PubMed ID: 28701916
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MIAT regulates blood tumor barrier permeability by functioning as a competing endogenous RNA.
He J; Xue Y; Wang Q; Zhou X; Liu L; Zhang T; Shang C; Ma J; Ma T
Cell Death Dis; 2020 Oct; 11(10):936. PubMed ID: 33127881
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA NEAT1 regulates permeability of the blood-tumor barrier via miR-181d-5p-mediated expression changes in ZO-1, occludin, and claudin-5.
Guo J; Cai H; Zheng J; Liu X; Liu Y; Ma J; Que Z; Gong W; Gao Y; Tao W; Xue Y
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2240-2254. PubMed ID: 28185956
[TBL] [Abstract][Full Text] [Related]
16. Role of ATP synthase alpha subunit in low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Xie H; Liu LB
J Neurol Sci; 2011 Jan; 300(1-2):52-8. PubMed ID: 21035144
[TBL] [Abstract][Full Text] [Related]
17. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood-Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Feb; 58(2):153-61. PubMed ID: 26358039
[TBL] [Abstract][Full Text] [Related]
18. Low-dose endothelial monocyte-activating polypeptide-ii increases permeability of blood-tumor barrier by caveolae-mediated transcellular pathway.
Li Z; Liu YH; Xue YX; Liu LB; Wang P
J Mol Neurosci; 2014 Mar; 52(3):313-22. PubMed ID: 24526454
[TBL] [Abstract][Full Text] [Related]
19. Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway.
Zhou W; Liu L; Xue Y; Zheng J; Liu X; Ma J; Li Z; Liu Y
Front Mol Neurosci; 2017; 10():68. PubMed ID: 28348518
[TBL] [Abstract][Full Text] [Related]
20. miR-34c regulates the permeability of blood-tumor barrier via MAZ-mediated expression changes of ZO-1, occludin, and claudin-5.
Zhao L; Wang P; Liu Y; Ma J; Xue Y
J Cell Physiol; 2015 Mar; 230(3):716-31. PubMed ID: 25201524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]